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CeramideMalignant gliomas are extremely resistant to therapies that induce apoptosis, but are less resistant
to therapies that induce autophagy. Therefore, drugs targeting autophagy are promising in the man-
agement of malignant gliomas. In this study, we investigated the anti-glioma potential of curcumin
in vitro, and further examined the molecular mechanisms of curcumin-induced cell death in human
malignant glioma. Here, we provide evidence that curcumin is cytotoxic against human malignant
glioma cell lines, and the mechanism of cell death caused by curcumin is associated with features of
autophagy. Curcumin suppresses the growth of human malignant glioma cells via ROS-dependent
prostate apoptosis response-4 (Par-4) induction and ceramide generation. Extracellular supplemen-
tation of antioxidants such as glutathione and N-acetylcysteine to glioma cells abrogated the Par-4
induction, ceramide generation, and in turn, prevented curcumin-induced autophagic cell death.
Moreover, tumor cells transfected with Par-4 gene sensitized the curcumin-induced autophagic cell
death. Overall, this study describes a novel signaling pathway by which curcumin induces ROS-
dependent Par-4 activation and ceramide generation, leading to autophagic cell death in human
malignant glioma cells.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Curcumin (also known as diferuloymethane) is the major yel-
low pigment extracted from turmeric (Curcuma longa), exerts a
wide spectrum of biological activities [1]. Curcumin possesses
potent antioxidant, anti-inﬂammatory, anti-viral and anti-bacterial
properties [1]. Indeed, curcumin also possess signiﬁcant chemo-
preventive efﬁcacy against various malignancies. A plethora of
studies have demonstrated the potent anticancer effect of curcu-
min both in vitro and in vivo on a wide variety of cancer models[2]. Moreover, curcumin has been shown to induce cell death in
apoptosis resistant cancer cells [3,4].
Autophagy is a so-called ‘self-eating’ cellular mechanism that
degrades damaged or obsolete proteins and organelles, the product
of which are recycled to generate macromolecules and ATP so as to
maintain the cellular homeostasis [5] . Recently, interest in autoph-
agy has been renewed amongst cancer biologists, since different
types of cancer cells were identiﬁed to undergo autophagy in
response to anticancer therapies [6]. Malignant glioma cells are
more likely to respond to therapy through autophagy than through
apoptosis. For instance, Temozolomide, one of the most efﬁcacious
chemotherapeutic agents employed in the treatment of glioma,
exerts its cytotoxicity by inducing autophagic cell death, and has
demonstrated a real therapeutic beneﬁt in apoptosis-resistant glio-
blastoma patients [7,8]. Thus, identiﬁcation of novel and efﬁcient
pro-autophagic drugs and elucidation of their molecular signaling
pathway, undoubtedly, will have a direct impact on future thera-
pies in the ﬁght against malignant glioblastoma.
It is widely accepted that oxidative stress can induce autophagy
[9,10]. It has been suggested that ROS have important signaling
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factor deprivation [11]. Moreover, tumor necrosis factor (TNF)-a
has been shown to induce autophagic cell death via a ROS-depen-
dent mechanism [12]. In another study, it has been shown that ROS
were both sufﬁcient and essential to induce autophagic cell death
in lipopolysaccharide-activated macrophages [13].
The prostate apoptosis response-4 (Par-4), a tumor suppressor
protein, was originally discovered in rat prostate cancer cells
when they were induced to undergo apoptosis [14,15]. Par-4
can selectively induce apoptosis in a wide variety of cancer cells,
leaving the normal cells unaffected. This selective nature of Par-4
makes it an attractive therapeutic option. Recently, it has been
reported that low Par-4 expression is associated with increase
in breast cancer recurrence [16]. These ﬁndings underscore the
importance of Par-4 as a tumor suppressor protein.
Ceramide is a sphingolipid which has been shown to exert
potent antitumor effect against a variety of cancer cells. A diverse
array of stressors, including TNF-a, Fas ligation, UV-irradiation,
heat shock, and anticancer drugs were reported to increase intra-
cellular ceramide level leading to the induction of apoptosis [17].
In addition to apoptosis, ceramide has more recently been impli-
cated in the induction of autophagy [18,19]. However, the precise
role and mechanism of ceramide in autophagy remains unclear.
To the best of our knowledge, this is the ﬁrst report to demon-
strate that curcumin induces autophagy, which is regulated by the
Par-4 up-regulation and ceramide generation via ROS-dependent
mechanism. Our ﬁnding suggests that curcumin has the potential
to be developed into a pro-autophagic drug for the treatment of
malignant gliomas.
2. Materials and methods
2.1. Chemicals and antibodies
Curcumin, glutathione (GSH), N-acetyl cysteine (NAC), 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT),
acridine orange (AO), 3-methyl adenine (3-MA), GW4869, desi-
pramine, phthaldialdehyde (OPA), dimethyl sulfoxide (DMSO),
anti-rabbit IgG and anti-mouse IgG were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). Oxidation sensitive DCFH-DA
(D-399) was from Molecular Probes (Eugene, OR, USA). Dul-
becco’s modiﬁed essential medium (DMEM), Opti MEM medium,
phosphate buffered saline (PBS), trypsin–EDTA and fetal bovine
serum (FBS) were from GIBCO BRL (Grand Island, NY, USA).
Fumonisin B1, myriocin, and z-VAD-fmk were from Alexis (San
Diego, CA, USA). Anti-actin, and anti-MAP LC3b (N-20), anti-
p62/SQSTM1, anti-Par-4 and donkey anti-goat IgG antibodies
were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA).
Anti-PARP, Anti-phospho AMPK Thr172, Anti-AMPK, Anti-phospho
LKB1 Ser428, LKB1, Anti-phospho mTOR Ser2448, anti-mTOR , anti-
phospho p70S6K Thr389, anti-p70S6K, anti-TFEB, anti-H3 and
anti-LC3B (D11) XP antibodies were from Cell Signaling
Technology (Beverly, MA, USA). Hydrogen peroxide was from
Merck Millipore. MegaTran 1.0 transfection reagent was from
OriGene.
2.2. Glioma cell lines, cell culture conditions and drug treatment
The cell lines U87MG and U118MG (ATCC, Rockville, MD, USA)
were grown in DMEM supplemented with 10% heat inactivated
FBS. All cell lines were grown without antibiotics in an incubator
containing humidiﬁed atmosphere of 95% air and 5% CO2 at
37 C. Curcumin stock solution (20 mM; in DMSO) was kept in a
dark colored bottle at 20 C. Cells were grown to about 70%
conﬂuences and then treated with curcumin at differentconcentrations (0–100 lM) and for different period of time (0–
24 h). Cells treated with a medium containing an equivalent
amount of DMSO without curcumin was served as control.
2.3. Cell viability and cytotoxicity assay
Cell viability following treatment with curcumin was assessed
by trypan blue dye exclusion test. After treatment with curcumin,
cells were detached with trypsin EDTA and trypan blue assays
were performed as described previously [20].
Cytotoxicity assay were carried out as described previously
[20]. After treatment with curcumin, 25 ll of MTT (5 mg/ml in
PBS) was added to each well and the assay was performed as
described previously [20].
2.4. Protein lysate preparation and Western blot analysis
Whole cell lysate with or without curcumin treatments were
prepared and performed Western blot analysis as described previ-
ously [20]. For preparing nuclear and cytosolic fractions cells were
washed twice in PBS and resuspended in 500 ll RSB buffer (10 mM
NaCl, 3 mMMgCl2 and 10 mM Tris–HCl, pH 7.4 and EDTA free Rosh
protease inhibitor tablets per 20 ml buffer) for 10 min on ice. Cells
were disrupted with a Dounce homogenizer until over 90% of the
cells were disrupted. The homogenate was centrifuged at 1000g
for 5 min at 4 C. The supernatant (cytosolic fraction) was trans-
ferred and nuclear pellet was washed with RSB buffer and proteins
were extracted with RIPA lysis buffer.
2.5. Measurement of intracellular ROS Levels
After the curcumin treatment, generation of ROS in the cells
was measured by oxidation-sensitive ﬂuorescent probe DCFH-DA
as described previously [20].
2.6. DNA fragmentation analysis
After the curcumin treatment, cells were washed with PBS and
incubated with 200 ll of lysis buffer (50 mM Tris–HCl (pH 7.5), 3%
non-ionic detergent IGEPAL CA-630 and 20 mM EDTA) for 10 min.
DNA fragments were isolated from the cells and analyzed as
described previously [21].
2.7. Intracellular ceramide measurement
Intracellular ceramide was measured as described previously
[22]. After the curcumin treatment, cells were washed in PBS
and lysed using ceramide assay lysis buffer (50 mM Tris (pH-
7.4) containing 0.4% IGEPAL CA 630) by freeze and thaw method.
The ﬁnal concentration of IGEPAL CA 630 in the assay was 0.2%.
The lysate was then heated at 70 C for 5 min in a water bath
and centrifuged at 12000 rpm for 10 min at 4 C. The reaction
was started by mixing 10 ll of supernatant with 10 ng recombi-
nant human neutral ceramidase enzyme (10 ll), and incubated
for 1 h at 37 C. After stopping the reaction by adding 55 ll of
stopping buffer (1:9, 0.07 M potassium hydrogen phosphate buf-
fer: methanol), the released SPH was derivatized with OPA as
described previously [22]. After incubation for 30 min at room
temperature in the dark, an aliquot of 25 ll was used for the cer-
amide analysis. HPLC analyses were conducted using Waters 1525
binary pump system. Waters XTerra RP18 (5 lm, 3  250 mm)
column was equilibrated with a mobile phase (20% methanol,
80% 1:9 stopping buffer) at a ﬂow rate of 0.5 ml/min. The ﬂuores-
cence detector (Waters 2475) was set at an excitation wavelength
of 340 nm and an emission wavelength of 455 nm.
Fig. 1. Induction of autophagy in glioma cells treated with curcumin. (A) Glioma cells stably transfected with GFP-LC3 were treated with indicated concentration of curcumin
for 24 h. After the treatment, curcumin-induced autophagy manifesting as GFP-LC3 puncta was assessed by ﬂuorescence microscopy (left). Quantitatively, puncta were
counted as described in the Section 2 (right). Data shown are means ± SD (n = 3) (⁄p < 0.01, verses control). (B) Glioma cells were treated with indicated concentration of
curcumin for 24 h and (C) with 60 lM curcumin for indicated time period. Western blot analysis of LC3-I and LC3-II were detected. Actin was used as loading control. (D) Cells
were treated with indicated concentration of curcumin for 24 h followed by staining with 1 lg/ml AO for 20 min at 37 C. A representative slide under ﬂuorescence
microscopy shows curcumin-induced AVOs displaying red bright ﬂuorescence staining (left). Quantitative analysis of cells with red bright ﬂuorescence using ﬂuorescence
activated cell sorter (right). (E) Cells were treated with 40 lM curcumin in the presence or absence of Baf A1 (250 nM) followed by Western blot analysis of LC3-II. Actin was
used as loading control. (F) Glioma cells were treated with indicated concentration of curcumin for 24 h and (G) with 60 lM curcumin for indicated time period. After the
treatment, level of p62/SQSTM1 was detected. Actin was used as loading control. (H) Cells were subjected to nuclear and/or cytosolic fractionation and blotted with antibody
against TFEB. H3 and actin were used as the loading control for nuclear and cytosolic fractions, respectively. (I) Cells were treated with 60 lM concentration of curcumin for
24 h and Western blot analysis of p-LKB1, LKB1, p-AMPK, AMPK, p-mTOR, mTOR, p-p70S6K and p70SK were performed. Actin was used as loading control.
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pCMV6-XL6-Par-4 (SC110969) and pCMV6-Myc-DDK-tagged
PAR-4 (RC202733) were purchased from OriGene Technologies,
Inc. The green ﬂuorescent protein (GFP)-tagged microtubule-asso-
ciated protein light chain 3 (LC3) expression vector, pEGFP-LC3
were obtained from Addgene 21073 (Dr. Tamotsu Yoshimori’s lab-
oratory, Osaka University, Osaka, Japan). DNA transfection to cellswas performed by using MegaTran 1.0 transfection reagent as
described in the manufacture’s protocol.
2.9. GFP-LC3 dot assay
U87MG and U118MG cells (stably transfected with pEGFP-LC3
using MegaTran 1.0 transfection reagent according to the manufac-
ture’s instruction) were treated with curcumin and formation of
Fig. 1 (continued)
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scope. To quantify LC3 puncta, 100 GFP-LC3 cells that had more
than 10 bright GFP-LC3 punctate spots were counted.
2.10. Detection and quantiﬁcation of acidic vesicular organelles (AVOs)
with AO staining
Cellswere incubatedwithAO (1 lg/ml) for 20 min and examined
underOlympusDP71ﬂuorescentmicroscope. To quantify the devel-
opment of AVOs, after incubationwith AO, cells were removed from
theplateusing trypsin–EDTA, resuspended inphenol red freeDMEM
and analyzed by BD FACSCanto II using BD FACSDiva software. A
minimum of 10,000 cells within the gated region were analyzed.
2.11. Statistical analysis
Each experiment was performed at least three times and data
are shown as the mean ± standard deviation. Statistical analysis
was performed using Graph pad Prism 5.0 by one-way anova and
Bonferroni post hoc test. A difference was considered signiﬁcant
when p < 0.05.3. Results
3.1. Curcumin activates autophagy in human malignant glioma cells
Autophagy has been postulated as a potential mechanism
whereby eukaryotic cells commit suicide by degrading their own
cytoplasmic organelles. In initial study, malignant glioma cells over
expressing GFP-LC3 were treated with curcumin in order to know
whether they undergo autophagy in response to the treatment. LC3
is the mammalian homologue of yeast Atg8. During autophagy,
GFP-LC3 converts from diffuse pattern to the accumulation of
puncta in the cytoplasm which represents an effective way of
detecting autophagosome formation [23]. Treatment of GFP-LC3
stable U87MG and U118MG cells with curcumin resulted in signif-
icant dose-dependent increase in the number of cells with punc-
tate ﬂuorescence (Fig. 1A).
LC3 protein is known to exist in two forms, LC3-I residing in the
cytosol and its phosphatidylethanolamine conjugated form LC3-II,
which is the major component of autophagosome. The amount of
LC3-II formation is considered as a good early marker for the
autophagy induction [23]. Treatment of glioma cells with curcumin
A B C
D 
G 
E 
F 
0 20 40 60 80 100
0
25
50
75
100
125
U87MG
U118MG
Cur (µM)
%
 V
ia
bi
lit
y
C
on
tro
l
C
ur
C
ur
+z
-V
AD
-fm
k
z-
VA
D
-fm
k
C
on
tro
l
C
ur
C
ur
+z
-V
AD
-fm
k
z-
VA
D
-fm
k
C
on
tro
l
C
ur
C
ur
+z
-V
AD
-fm
k
z-
VA
D
0
25
50
75
100
125
150
U87 MG U118 MG Jurkat
%
 V
ia
bi
lit
y
* * * *
Fig. 2. Curcumin induces caspase-independent cell death in human malignant glioma cells. (A) Glioma cells were treated with the indicated concentration of curcumin for
24 h and (B) with 60 lM curcumin for the indicated time period. Cell viability was assessed by MTT assay. Data shown are means ± SD (n = 3). (C) Cells were treated with
indicated concentrations of curcumin for 24 h and cell viability was assessed by trypan blue dye exclusion test. (D) Morphological changes by curcumin treatment in U87MG
and U118MG cells. (E) PARP cleavage was determined by Western blot analysis. (F) DNA fragmentation was analyzed as described in the Section 2. Jurkat cells, treated or
untreated with curcumin (25 lM), were used as a positive control for apoptotic PARP cleavage and DNA fragmentation. (G) Cells were pretreated with z-VAD-fmk (50 lM) for
1 h before curcumin (60 lM) treatment for further 24 h and cell viability was measured using MTT assay. Similar experiment in Jurkat cells using 25 lM curcumin were used
as a positive control. Data shown are means ± SD (n = 3) (⁄p < 0.01).
F. Thayyullathil et al. / FEBS Open Bio 4 (2014) 763–776 767resulted in a signiﬁcant increase in LC3-II levels in both dose- and
time-dependent manner (Fig. 1B and C). To further clarify the abil-
ity of curcumin to induce autophagy, we examined the develop-
ment of AVOs with AO staining, followed by ﬂuorescentmicroscopy and ﬂow cytometry as reported previously [24]. Treat-
ment of glioma cells with curcumin led to accumulation of AO-
stained orange–red acidic vesicles resembling autolysosomes
(Fig. 1D). The quantitative analysis of AO-stained cells
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Fig. 3. Effect of 3-MA on curcumin-induced autophagic cell death in human malignant glioma cells. (A) Glioma cells stably transfected with GFP-LC3 were pretreated with 3-
MA (2.5 mM) for 1 h followed by curcumin (40 lM) treatment for 24 h. After the treatment, curcumin-induced GFP-LC3 dots were assessed by ﬂuorescence microscopy (left).
Quantitatively, puncta were counted as described in Section 2 (right). Data shown are means ± SD (n = 3). (B) U87MG and U118MG cells were pretreated with 3-MA (2.5 mM)
for 1 h followed by curcumin (40 lM) treatment for 24 h. After the treatment, cells were stained with 1 lg/ml AO for 20 min at 37 C. A representative slide under
ﬂuorescence microscopy shows curcumin-induced AVOs displaying red bright ﬂuorescence (left). Quantitative analysis of cells with red bright ﬂuorescence using
ﬂuorescence activated cell sorter (right). (C) Cell viability was assessed by MTT assay. Data shown are means ± SD (n = 3) (⁄p < 0.01 and #p < 0.05).
768 F. Thayyullathil et al. / FEBS Open Bio 4 (2014) 763–776demonstrated a dramatic increase in red ﬂuorescence in U87MG
cells from 8.1% to 38.9%, and in U118MG cells from 5.6% to 22.3%
(Fig. 1D).
Next, we examined the autophagic ﬂux by LC3 turnover assay,
which measures the autolysosomal degradation of LC3-II by com-
paring the amount of LC3-II in the presence and absence of the
autolysosome formation inhibitor baﬁlomycin A1 (BafA1).Treatment with BafA1 resulted in a signiﬁcant increase in endoge-
nous LC3-II accumulation. The BafA1-induced LC3-II accumulation
was apparently augmented in cells exposed to curcumin (Fig. 1E),
suggesting an increase in the autophagic ﬂux. To further conﬁrm
the autophagic ﬂux, the effects of curcumin on the expression of
p62/SQSTM-1, an LC3-intracting protein degraded in the autolyso-
somes [23] was examined. Treatment of U87MG and U118MG cells
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Fig. 4. Curcumin induces intracellular ROS-mediated autophagy and cell death in human malignant glioma cells. (A) U87MG and (B) U118MG cells were treated with
curcumin (60 lM) for indicated time period. Following the treatment, cells were stained with DCFH-DA and analyzed by ﬂuorometry. Data shown are means ± SD (n = 3)
(⁄p < 0.05, verses control). (C) Glioma cells stably transfected with GFP-LC3 were pretreated with GSH (10 mM) and NAC (10 mM) for 1 h followed by curcumin (40 lM)
treatment for 24 h. After the treatment, curcumin-induced GFP-LC3 dots were assessed by ﬂuorescence microscopy (left). Quantitatively, puncta were counted as described in
Section 2 (right). Data shown are means ± SD (n = 3). (⁄p < 0.01, verses control and ⁄⁄p < 0.01, verses curcumin). (D) Cells were pretreated with GSH (10 mM) and NAC (10 mM)
for 1 h followed by curcumin (40 lM) treatment for 24 h. After the treatment, cell extracts were prepared for the detection of LC3-II and p62/SQSTM1 by Western blot
analysis. Actin was used as loading control. (E) Cells were stained with 1 lg/ml AO for 20 min at 37 C. A representative slide under ﬂuorescence microscopy shows curcumin-
induced AVOs displaying red bright ﬂuorescence. (F) Cell viability was assessed by MTT assay. Data shown are means ± SD (n = 3) (⁄p < 0.01, verses control and ⁄⁄p < 0.01,
verses curcumin).
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770 F. Thayyullathil et al. / FEBS Open Bio 4 (2014) 763–776with curcumin resulted in a dose- and time-dependent decrease in
detectable p62/SQSTM1 protein level (Fig. 1F and G). Altogether,
these data illustrate the ability of curcumin to increase autophagy
in human malignant glioma cells.
It has been reported that transcription factor EB (TFEB), a mas-
ter gene for lysosomal biogenesis, has an important role in the
induction of autophagy by positively regulating the expression of
several autophagy genes [25]. To achieve this TFEB, which nor-
mally resides in the cytosol, must translocate to the nucleus [25].
In order to investigate whether TFEB translocates to the nucleus
during the curcumin-induced autophagy, both glioma cells were
treated with 0–40 lM curcumin for 24 h. After the treatment,
nuclear fractions were isolated and Western blot analysis was per-
formed. As shown in the Fig. 1H, treatment of glioma cells with
curcumin, indeed, resulted in an efﬁcient TFEB nuclear
translocation.
Previously, it has been reported that LKB1/AMPK activation
leads to the induction of autophagy through negative regulation
of mTOR [26,27]. Therefore, we examined whether phosphoryla-
tion of LKB1 and AMPK are involved in the curcumin-induced
autophagy in human malignant glioma cells. As shown in the
Fig. 1I, treatment of both U87MG and U118MG cells with curcumin
resulted in the phosphorylation of LKB1 and its downstream target
AMPK in a time dependent manner. In line with this, curcumin
treatment also resulted in the dephosphorylation of mTOR and
its downstream target p70S6K in human malignant glioma cells
(Fig. 1I). Taken together, these ﬁndings indicate that LKB1/AMPK/
mTOR/p70S6K pathway is involved in the curcumin-induced
autophagy in human malignant glioma cells.
3.2. Curcumin induces caspase-independent cell death associated with
features of autophagy
To ascertain the antitumor action of curcumin, the effect of cur-
cumin on the viability of both U87MG and U118MG cells were
examined by using MTT assay. As shown in Fig. 2A and B, exposure
of glioma cells to curcumin resulted in both a dose- and a time-
dependent reduction in viability. Since changes in cellular metab-
olism may affect the MTT assay, cell viability were also measured
using trypan blue dye exclusion test. As shown in Fig. 2C, trypan
blue data correlates to the MTT data. Morphological analysis shows
that curcumin treated cells were rounded up, swelled and
detached from the dish, without the presence of apoptotic bodies
(Fig. 2D). In malignant cells, curcumin has also been reported to
induce apoptosis which is characterized by caspase-3 activation
and PARP cleavage, prime hallmark of apoptotic cell death [28].In order to know whether the cytotoxic effect of curcumin on these
glioma cells is associated with induction of apoptosis, U87MG and
U118MG cells were treated with increasing concentrations of cur-
cumin for 24 h, and PARP cleavage was examined. As shown in the
Fig. 2E, curcumin treatment did not induce PARP cleavage in these
two glioma cells tested. Whereas, a solid PARP cleavage was evi-
dent in Jurkat cells which is used as a positive control [28]. In line
with this, curcumin treatment also failed to induce ‘‘DNA ladder’’
fragmentation, a typical marker for cells undergoing apoptosis
(Fig. 2F). Whereas, a pattern of apoptotic DNA fragmentation was
evident in Jurkat cells treated with curcumin. Additionally, we per-
formed MTT viability assay in cells stimulated with curcumin in
the presence and absence of pan caspase inhibitor z-VAD-fmk. Cell
death induced by curcumin was not attenuated by the z-VAD-fmk
in malignant glioma cells (Fig. 2G). However, pretreatment with z-
VAD-fmk signiﬁcantly inhibited the curcumin-induced cell death
in Jurkat cells (Fig. 2G). Taken together, these data strongly suggest
that curcumin induces caspase-independent death in human
malignant glioma cells.
3.3. 3-Methyladenine decreases curcumin-induced autophagy and
cytotoxicity
Pretreatment with 3-MA (a most commonly used autophagy
inhibitor) signiﬁcantly reduced the curcumin-induced GFP-LC3
puncta formation (Fig. 3A), AVOs formation (Fig. 3B), and also
partly protected the curcumin-induced cytotoxicity (Fig. 3C). These
ﬁndings indicate that, the mechanism of anticancer activity of cur-
cumin in glioma cells is partially attributable to the induction of
autophagy.
3.4. Curcumin triggers intracellular ROS generation in human
malignant glioma cells
Recently, several reports provided strong evidence for the
involvement of ROS in the induction of autophagy in response to
chemotherapy-induced stress [9,10]. Furthermore, curcumin has
shown to induce rapid accumulation of ROS which leads to cas-
pase-dependent and -independent apoptosis [20]. In order to
understand the involvement of ROS in curcumin-induced autoph-
agy, both U87MG and U118MG cells were stained with DCFH-DA
followed by curcumin treatment. Curcumin treatment resulted in
an increase in DCFH-DA derived ﬂuorescence by 7-fold in U87MG
cells within 30 min, and by 2.5-fold in U118MG cells within
5 min (Fig. 4A and B). To know if ROS has any role in curcumin-
induced autophagy, both U87MG and U118MG cells were pre-
F. Thayyullathil et al. / FEBS Open Bio 4 (2014) 763–776 771treated with thiol-based ROS scavengers, namely GSH (10 mM) or
NAC (10 mM), followed by the treatment with curcumin. Attenua-
tion of ROS levels by GSH and NAC almost completely abolished
curcumin-induced GFP-LC3 puncta formation (Fig. 4C), LC3-II con-
version and p62/SQSTM1 degradation (Fig. 4D), AVOs formation
(Fig. 4E) and cell death (Fig. 4F).
Extracellular addition of H2O2 can be used to mimic the effects
of intracellularly produced ROS [10,29]. In order to further conﬁrm
the involvement of ROS in curcumin-induced autophagy, U87MG
cells were treated with 2 mM H2O2 for 24 h. As expected, H2O2
treatment resulted in an increase in GFP-LC3 puncta formation
(Supplementary Fig. 1A), AVOs formation (Supplementary
Fig. 1B) and cell death (Supplementary Fig. 1C). All together, theseFig. 5. Involvement of Par-4 in curcumin-induced autophagy in human malignant gliom
curcumin for 24 h and (B) with 60 lM curcumin for indicated time period. Western blo
pretreated with GSH (10 mM) and NAC (10 mM) for 1 h followed by curcumin (60 lM)
loading control. (D) U87MG and U118MG cells were treated with 2 mM and 0.5 mM H2O
as loading control. (E) pCMV6-DDK-Par-4 and empty vector transiently transfected U87M
After the treatment, cells were stained with 1 lg/ml AO for 20 min at 37 C. A repre
Quantitative analysis of cells with red bright ﬂuorescence using ﬂuorescence activated c
Quantitatively, puncta were counted as described in Section 2 (right). Data shown are m
SQSTM1 and PARP were detected using the corresponding antibodies. Actin was used
means ± SD (n = 3) (⁄p < 0.01 and #p < 0.05).ﬁndings suggest the prime role of ROS in curcumin-induced auto-
phagic cell death in malignant glioma.
3.5. Curcumin-induced autophagic cell death is associated with the
ROS-dependent induction of Par-4 in human malignant glioma cells
Prostate apoptosis response-4 is a pro-apoptotic tumor-sup-
pressor protein that selectively induces apoptosis in cancer cells
[14]. Previously, we have reported that curcumin induces cas-
pase-3-dependent cleavage of Par-4 that leads to the induction of
apoptosis [21]. In order to know whether Par-4 is involved in cur-
cumin-induced autophagic cell death, the effect of curcumin on
Par-4 expression was tested. Curcumin treatment resulted in sig-a cells. (A) U87MG and U118MG cells were treated with indicated concentration of
t analysis of Par-4 was detected. Actin was used as loading control. (C) Cells were
treatment for 24 h. Western blot analysis of Par-4 was detected. Actin was used as
2, respectively followed by Western blot analysis of Par-4 and LC3-II. Actin was used
G and U118MG cells were treated with either vehicle or curcumin (25 lM) for 24 h.
sentative slide under ﬂuorescence microscopy shows H2O2-induced AVOs (left).
ell sorter (right). (F) GFP-LC3 dots were assessed by ﬂuorescence microscopy (left).
eans ± SD (n = 3) (⁄p < 0.01 and #p < 0.05). (G) The levels of DDK-Par-4, LC3-II, p62/
as loading control. (H) Cell viability was assessed by MTT assay. Data shown are
772 F. Thayyullathil et al. / FEBS Open Bio 4 (2014) 763–776niﬁcant up-regulation of Par-4 in a dose- and time-dependent
manner in both glioma cells tested (Fig. 5A and B).
Since curcumin-induced ROS generation was an early event, it is
possible that ROS generation could lead to Par-4 induction. In order
to test this, both glioma cells were pretreated with GSH and NAC
for 1 h, followed by treatment with curcumin for 24 h, and the
expression of Par-4 was measured. As shown in the Fig. 5C, both
GSH and NAC completely abrogated the curcumin-induced Par-4
induction. To conﬁrm this further, U87MG and U118MG cells were
treated with 2 mM and 0.5 mM H2O2 respectively, and the expres-
sion of Par-4 and LC3-II were analyzed. As shown in the Fig. 5D,
H2O2 treatment resulted in signiﬁcant induction of Par-4 expres-
sion and LC3-II formation in both glioma cells. All together, these
data indicate that curcumin-induced Par-4 induction was medi-
ated via ROS generation.
Overexpression of Par-4 sensitizes cancer cells to apoptosis in
response to various apoptosis inducing agents [30]. In order to
examine whether Par-4 overexpression leads to induction of
autophagy, glioma cells transiently expressing Par-4 or cells
expressing the empty vector control, were exposed to curcumin
treatment. The cells were then stained with AO, and analyzed by
ﬂuorescent microscopy and FACS analysis. As shown in Fig. 5E, cur-
cumin treatment resulted in a marked increase in the orange–red
acidic vesicles in Par-4 overexpressed cells. More importantly,
Par-4 overexpression alone was sufﬁcient to induce autophagic
features in both glioma cell types. To conﬁrm our observation by
additional methods, cells were subjected to LC3 puncta analysis
and immuno blot analysis of LC3 conversion and p62/SQSTM1Fig. 5 (contdegradation. As expected, expression of Par-4 signiﬁcantly
increased the number of autophagic LC3 puncta (Fig. 5F), LC3-II
formation (Fig. 5G) and p62/SQSTM1 degradation (Fig. 5G). More-
over, the curcumin-induced cell death was potentiated in the pres-
ence of Par-4 (Fig. 5H). Since the role of Par-4 is best-known in
promoting apoptosis, we further investigated to know whether
sensitization of curcumin-induced cell death by Par-4 is as a result
of apoptosis. As shown in Fig. 5G, Par-4 overexpression together
with curcumin treatment did not cause the PARP cleavage, a prime
marker for apoptosis. Taken together, ROS-dependent up regula-
tion of Par-4 regulates curcumin-induced autophagy in glioma
cells.
3.6. Curcumin induces autophagy concomitant with ceramide
generation in human malignant glioma cells
In addition to its role in apoptosis, ceramide has more recently
been implicated in the induction of autophagy [18,19]. To investi-
gate the involvement of ceramide in curcumin-induced autophagic
cell death, both U87MG and U118MG cells were treated with var-
ious concentrations of curcumin (0–80 lM for 24 h), and for differ-
ent time periods (60 lM for 0–24 h), and ceramide generation was
examined. Curcumin treatment resulted in a dose- and time-
dependent accumulation of ceramide in both glioma cell lines
(Fig. 6A and B).
Ceramide generation may proceed from either the de novo syn-
thesis, or sphingomyelin hydrolysis [17]. To know which of these
pathways is involved in curcumin-induced ceramide generation,inued)
F. Thayyullathil et al. / FEBS Open Bio 4 (2014) 763–776 773U87MG cells were pretreated with inhibitors targeting these path-
ways followed by treatment with curcumin. The de novo synthesis
inhibitors such as fumonisin B1 and myriocin, and acid sphingo-
myelinase inhibitor, desipramine exerted no effects on curcumin-
induced ceramide generation, autophagy and cell death (Supple-
mentary Fig. 2A, B, and C). In contrast, neutral sphingomyelinase
inhibitor GW4869 [31], partially but signiﬁcantly blocked
curcumin-induced ceramide generation (Fig. 6C), autophagy
(Fig. 6D) and cell death (Fig. 6E). This suggests that neutral sphin-
gomyelinase-mediated ceramide generation, at least in part, plays
a role in curcumin-induced cell death in U87MG malignant glioma
cells.
The oxidative stress and ceramide pathways have been linked
in number of previous studies [32]. Since curcumin-induced ROS
generation was rapid in comparison with ceramide accumulation,
it is plausible that ROS generation precedes the ceramide accumu-
lation. In order to examine this possibility, both glioma cells were
pretreated with GSH and NAC for 1 h followed by treatment with
curcumin for 24 h, and ceramide levels were measured. As shown
in Fig. 6F, GSH and NAC pretreatment, completely abrogated the
ceramide accumulation, indicating that curcumin induces ROS-
dependent ceramide generation and autophagic cell death in
human malignant glioma cells.Fig. 5 (cont4. Discussion
Autophagy plays critical role in the generation of antineoplastic
responses in malignant glioma cells [6–8]. The mechanism by
which autophagy mediates cell death is entirely different from that
of apoptosis.
In the present study, we investigated the ability of curcumin to
induce autophagic cell death in human malignant glioma cells and
the functional consequences of such an induction. Our results show
that curcumin exhibits a potent pro-autophagic effect on human
malignant glioma cells, as demonstrated by AVOs formation,
GFP-LC3 punctate formation, increased LC3-II conversion, p62/
SQSTM1 degradation, and TFEB nuclear translocation. Curcumin-
induced autophagy and cell death was marginally rescued by a
well-known early phase autophagy inhibitor 3-MA. We also pro-
vide evidence that pro-autophagic effect of curcumin occurs via
rapid generation of ROS, leading to the up-regulation of Par-4
and ceramide. This is extremely important, since Par-4 and cera-
mide were considered as important tumor suppressor protein
and lipid, respectively [14,15,17].
An emerging body of evidence indicate that activation of LKB1/
AMPK pathway is associated with autophagy in cancer cells. Acti-
vated AMPK induces autophagy by inhibiting mTOR, a key negativeinued)
774 F. Thayyullathil et al. / FEBS Open Bio 4 (2014) 763–776regulator of autophagy [26,27]. Our results demonstrate that treat-
ment of glioma cells with curcumin resulted in activation of LKB/
AMPK, which in turn leads to inactivation of mTOR and its down-
stream target p70S6K.
Accumulating evidence suggest that ROS generation is an
important regulator for autophagy [9,10]. Some of the anticancer
agents have been shown to induce ROS generation on its en route
to induce autophagic cell death [33–35]. Blocking the ROS genera-
tion by using antioxidants inhibited the autophagic cell death, indi-
cating the prime role that ROS in mediating the autophagic
response [33–35]. In this regard, it was of interest to determine
the functional link between ROS and autophagy in curcumin-
induced cell death. In the present study, we demonstrate a rapid
accumulation of ROS following curcumin treatment. Inhibition of
this ROS accumulation with GSH and NAC almost completely abro-
gated the curcumin-induced autophagy and cell death. Results
from this study are consistent with previous reports in which anti-
cancer drugs were demonstrated to induce ROS production, and a
resultant accelerated autophagy and cell death [34,35].Fig. 5 (contThe tumor suppressor protein Par-4 is considered as an impor-
tant target for cancer therapeutic intervention, since it selectively
induces apoptosis in cancer cells; but not in normal cells [15].
Investigations are still undergoing to elucidate the mechanism by
which Par-4 exhibits its function in the cell. Earlier studies indicate
that Par-4 is strongly up-regulated in cells undergoing apoptosis
[14]. In contrast, our data shows that Par-4 is signiﬁcantly up-reg-
ulated in curcumin-induced autophagic cell death in humanmalig-
nant glioma cells. Very recently, Wang et al. reported the
simultaneous induction of apoptosis and autophagy by Par-4 in
hypopharyngeal carcinoma cells [36]. Given that curcumin induces
Par-4 expression in human malignant glioma cells, we investigated
whether Par-4 has any role in autophagy. Our experiment shows
that overexpression of Par-4 sensitizes curcumin-induced autoph-
agy and cell death. Moreover, Par-4 overexpression alone was suf-
ﬁcient to induce cell death which is associated with features of
autophagy as evidenced by increased AVOs formation, GFP-LC3
punctate formation, LC3-II conversion and p62/SQSTM1 degrada-
tion. Antioxidants such as GSH and NAC completely inhibited theinued)
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Fig. 6. Curcumin induces ceramide generation in human malignant glioma cells. (A) U87MG and U118MG cells were treated with indicated concentration of curcumin for
24 h and (B) with 60 lM curcumin for indicated time period. The ceramide levels were measured as described in the Section 2. Data represent the mean ± SD (n = 3) (⁄p < 0.01,
verses control) (C) U87MG cells were pretreated with GW4869 (25 lM) for 1 h followed by curcumin (60 lM) treatment for 24 h. After the treatment, ceramide levels were
measured as described in the Section 2. Data represent the mean ± SD (n = 3) (⁄p < 0.01 and #p < 0.05). (D) The dots of GFP-LC3 were assessed by ﬂuorescence microscopy
(left). Quantitatively, puncta were counted as described in Section 2 (right). Data shown are means ± SD (n = 3). (E) Cell viability was assessed by MTT assay. Data represent
the mean ± SD (n = 3) (⁄p < 0.01 and #p < 0.05). (F) U87MG and U118MG cells were pretreated with GSH (10 mM) and NAC (10 mM) for 1 h followed by curcumin (60 lM)
treatment for 24 h. After the treatment, ceramide levels were measured as described in the Section 2. Data represent the mean ± SD (n = 3) (⁄p < 0.01).
F. Thayyullathil et al. / FEBS Open Bio 4 (2014) 763–776 775curcumin-mediated Par-4 induction. Extracellular treatment of
H2O2 also induced Par-4 and demonstrated features of autophagic
cell death in human malignant glioma cells. Taken together these
data clearly suggest that Par-4 has a vital role in curcumin-induced
autophagic cell death in malignant glioma cells.Ceramide has emerged as an important lipid mediator in the
induction of apoptotic and autophagic cell death in variety of
human tumor cells [18,19]. Recently, we have reported that curcu-
min induces caspase-dependent ceramide generation and apopto-
sis in human leukemic cells [28]. In this study, we demonstrate
776 F. Thayyullathil et al. / FEBS Open Bio 4 (2014) 763–776that curcumin treatment resulted in a dose- and time-dependent
accumulation of ceramide content in both cell lines. The fact that
the kinetics of autophagic cell death and ceramide generation par-
allels each other, suggests an involvement of ceramide in curcu-
min-induced autophagy. In this context, our results show that
curcumin-induced rapid ROS generation, increases intracellular
ceramide level, and speciﬁcally induces autophagy. Additionally,
GW4869, an inhibitor of neutral sphingomyelinase, signiﬁcantly
blocked curcumin-induced ceramide generation, autophagy and
subsequently decreased cell death in U87MG cells. We also dem-
onstrate that extracellular supplementation of antioxidants to
human malignant glioma cells completely inhibited the ceramide
production. All together, these studies support a signiﬁcant role
for ceramide in triggering curcumin-induced autophagy in human
malignant glioma cells.
The present study provides the ﬁrst mechanistic evidence that
curcumin is highly effective in suppressing the growth of human
malignant glioma cells via autophagic cell death, which is associ-
ated with ROS-dependent up-regulation of Par-4, and ceramide
generation. These ﬁndings not only add a novel concept to our
understanding of curcumin-induced cell death pathway but also
may serve as a powerful stimulus to design a curcumin based
pro-autophagic drug for the treatment of brain tumor.
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